EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report

Anastasia S Fatyanova, Maria E Kalinina, Dina F Islamova, Igor O Shchekoturov, Julia V Lerner, Nadezhda A Stashevskaya, Pavel Burko, Ilias Miltiadis iD

Cancer Reports · 2026-06 · 9 (6)

DOI: 10.1002/cnr2.70595 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Reports, online erschienen am 04.06.2026. Verfasst von Anastasia S Fatyanova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sechenov University, Moscow, Russia. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Neoplasms, Second Primary, Carcinoma, Pancreatic Ductal. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with most patients presenting with advanced disease. Surgical resection remains the only potentially curative option, yet recurrence rates are high. Case We present a rare case of metachronous primary pancreatic neuroendocrine tumor (PanNET) and PDAC in a 71‐year‐old female. Initial management of stage IA PanNET (pT1N0M0) involved pancreatoduodenectomy (Whipple procedure) in 2022. One year later, the patient developed primary PDAC (pT2N1M0, stage IIB) in the remnant pancreas and was treated with completion pancreatectomy. Postoperative complications (reactive thrombocytosis and type 3c diabetes) precluded adjuvant chemotherapy. Subsequent hepatic progression was controlled for 12 months with first‐line gemcitabine before progression necessitated second‐line irinotecan.

Conclusion

This case highlights the challenges of managing sequential primary pancreatic malignancies, the impact of total pancreatectomy complications on therapeutic options, and the potential for disease control with sequential systemic therapy even after aggressive recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsNeoplasms, Second PrimaryCarcinoma, Pancreatic DuctalHumansFemaleAgedPancreatectomyPancreaticoduodenectomy

Autor:innen und Institutionen

  • Sechenov University, Moscow, Russia.
  • RUDN University, Moscow, Russia.
  • Synergy University, Moscow, Russia.
  • Department of Biomedicine, Neuroscience and Advanced Diagnostics (BIND), University of Palermo, Palermo, Italy.

ORCID-Profile: Ilias Miltiadis

Zitieren

APA

Fatyanova, A. S., Kalinina, M. E., Islamova, D. F., Shchekoturov, I. O., Lerner, J. V., Stashevskaya, N. A., Burko, P., & Miltiadis, I. (2026). Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report. Cancer Reports, 9(6). https://doi.org/10.1002/cnr2.70595

Vancouver

Fatyanova AS, Kalinina ME, Islamova DF, Shchekoturov IO, Lerner JV, Stashevskaya NA, et al. Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report. Cancer Reports. 2026;9(6). doi:10.1002/cnr2.70595

BibTeX
@article{Fatyanova2026,
  author = {Fatyanova, Anastasia S and Kalinina, Maria E and Islamova, Dina F and Shchekoturov, Igor O and Lerner, Julia V and Stashevskaya, Nadezhda A and Burko, Pavel and Miltiadis, Ilias},
  title = {Metachronous Primary Pancreatic Neuroendocrine Tumor and Adenocarcinoma: A Case Report},
  journal = {Cancer Reports},
  year = {2026},
  volume = {9},
  number = {6},
  doi = {10.1002/cnr2.70595}
}
Kostenlos starten →